ABSTRACT
The decision to undergo apoptosis lies in the balance between pro-and anti-apoptotic proteins. Since virus replication relies on the cellular machinery, viruses have evolved various strategies to alter this balance. They target the Bcl-2 and signaling protein kinase (PK) apoptosis modulatory families by encoding homologues or altering the expression of the cellular proteins. The heat shock proteins (Hsp) are emerging as a new family of apoptosis modulatory proteins and are also a target of virus modification. Hsp function in protein folding and activation, often assisted by co-chaperones. They complex with nascent or damaged proteins and chaperone them for refolding and resumption of function, or for proteosomal degradation. Until recently, Hsp were considered strictly anti-apoptotic, possibly by virtue of their contribution to the removal of damaged and undesirable client proteins. However, recent studies have also begun to associate the Hsp with pro-apoptotic functions (1) . Herpes simplex virus type 2 (HSV-2) encodes two proteins homologous to Hsp family members. One of these, known as ICP10PK, is a homologue to a newly cloned Hsp (H11) and modulates virus-induced apoptosis. ICP10PK is unique among the viral proteins that regulate apoptosis in that it targets all the families of apoptosis modulatory proteins. It activates the ERK signaling pathway, stabilizes Bcl-2 and upregulates Hsp70 and Hsp27 as well as the Hsp70 co-chaperone Bag-1. Its ability to commandeer these families of apoptosis regulators is required for HSV-2 replication and latency establishment/ reactivation.
INTRODUCTION
Unlike eukaryotic and prokaryotic organisms, viruses are unable to replicate independently. They evolved various strategies to hijack the cells, forcing them to become virus producing factories. A basic mechanism used by the cells to escape virus control is programmed cell death, also known as apoptosis. Apoptosis limits virus replication and prevents/reduces the infection of neighboring uninfected cells. It is an irreversible process Figure 1 . Protein kinase signaling pathways and apoptotic cascade. Schematic representation of protein kinase signaling pathways involved in apoptosis regulation. The intrinsic apoptosis cascade involves release (dashed arrows) of pro-apoptotic mediators such as cytochrome c (Cyt c) and Smac/DIABLO (Smac) resulting in caspase-9 and -3 activation and apoptosis. The extrinsic pathway involves "death" receptor activation such as interaction of Fas-ligand with Fas or tumor necrosis factor alpha (TNF-alpha) with the TNF receptor (TNFR) leading to capase-8 or -10 activation and resulting in activation of caspase-3 directly or by activating the intrinsic pathway. Activation of the death receptors can also lead to apoptosis through activation of c-Jun Nterminal kinase (JNK) or p38MAPK (p38) through activation of apoptosis signaling kinase 1 (ASK-1). Activation of a receptor tyrosine kinase (RTK) on the cell surface can inhibit apoptosis by activating the Ras/Raf/MEK/ERK signaling pathway or the phosphatidylinositol 3-kinase (PI3K)/ AKT signaling pathway. The Ras signaling pathway can also be activated by the interaction of integrins with the extracellular matrix such as collagen. Solid arrows indicate activation while solid lines resembling the letter T signify inhibition.
regulated by gene families that consist of pro-and antiapoptotic members and the balance of which determines the cell's fate. Viruses have evolved various strategies to utilize the apoptosis modulatory genes in order to insure their survival. Here, we briefly review some of these mechanisms focusing on Hsp and an HSV-2 protein (ICP10PK), that is an Hsp homologue (2,3).
APOPTOSIS MODULATORY GENE FAMILIES
Apoptosis is a tightly regulated, irreversible process that results in cell death in the absence of inflammation. Execution of the apoptotic death program is an energy dependent process. It requires expression and activation of proteins which ultimately lead to nuclear and cytoplasmic condensation, intranucleosomal DNA cleavage, and blebbing of the cell into membrane-bound apoptotic bodies. Classically, apoptosis is mediated by cysteine proteases with aspartate specificity known as caspases. Signaling cascades involved in apoptosis are schematically represented in Figure 1 .
Functionally distinct protein families regulate apoptosis. Two of these, the Bcl-2 and PK signaling proteins, are well recognized. The Bcl-2 family consists of over 20 proteins all of which contain at least one Bcl-2 homology domain (BH1-BH4). They regulate apoptosis by affecting mitochondrial permeability (4) . The group consists of pro-and anti-apoptotic members that form homo-and heterodimers, regulating each others' function. Pro-apoptotic members, such as Bax and Bak, homodimerize leading to the permeablization of the mitochondrial outer membrane and the release of cytochrome c and apoptosis inducing factor (AIF). Anti-apoptotic members, such as Bcl-2 or Bcl-X L , form heterodimers with Bax and Bak, thereby preventing mitochondrial permeablization.
A diverse group of PKs that trigger pro-or antiapoptotic signaling pathways (Figure 1 ) are also known to regulate apoptosis. Pro-apoptotic signaling pathways, such as those induced by environmental stress stimuli or the oligomerization of death receptors result in the recruitment of apoptosis-regulating kinase 1 (ASK1) and lead to activation of the pro-apoptotic c-Jun N-terminal kinase (JNK) and p38MAPK protein cascades (5) . Anti-apoptotic signaling pathways are triggered by survival stimuli. One of these pathways involves a kinase cascade that initiates with c-Raf-1 and involves phosphorylation (activation) of MAP kinase kinase (MEK) and extracellular signalregulated kinase (ERK, also known as MAPK). Another of the survival anti-apoptotic pathways involves Akt whose targets, along with ERK, include genes required for cell cycle progression and the altered balance between pro-and anti-apoptotic Bcl-2 proteins (6,7). Activation of the ERK or Akt survival pathways can override apoptotic cascades triggered by various stimuli (8, 9) .
Proteins in the inhibitor of apoptosis protein (IAP) family also regulate apoptosis (Figure 1 ). IAPs are characterized by the presence of one to three zinc binding regions of ~70 amino acids in length known as baculovirus IAP repeat (BIR) domains (10). Family members inhibit apoptosis by direct interaction with caspase-3, -7, or -9 (10). Pro-apoptotic members have not yet been identified. To inhibit IAP activity, mitochondria release Smac/Diablo which binds IAP, thereby allowing caspase activity (11) (Figure 1 ).
HEAT SHOCK PROTEINS ARE AN APOPTOSIS REGULATORY FAMILY
Hsp are a newly emerging family of apoptosis regulators. They are highly conserved proteins which are upregulated by various stress conditions and function as molecular chaperones in regulating homeostasis. Virtually all family members are associated with thermotolerance and cytoprotection (12) , attributed at least in part, to apoptosis inhibition (13) . However, the exact mechanism of Hsp anti-apoptotic activity is still unclear, and Hsp overload after extreme stress can also contribute to apoptosis (14) . Increased Hsp expression can lead to their translocation to the cell surface, thereby increasing immune mediated cell death (15) , and they can enhance other apoptotic signals (16, 17). A recent report that an Hsp family member (H11) has its own pro-apoptotic activity (1) establishes the Hsp as a bona fide family of apoptosis regulators that consist of both pro-and anti-apoptotic members.
Hsp are known to function in protein folding and activation, assisted by co-chaperones, such as Bag-1. Hsp70 complexes with nascent or damaged proteins and chaperones them for refolding and function resumption, or for degradation by the proteosome complex. Bag-1 is an Hsp70 co-chaperone that interacts with the ATP binding site of Hsp70. Through this interaction, (i.e. by competing for binding to the Hsp70 ATPase binding domain), Bag-1 downregulates the refolding chaperone properties of Hsp70 with client proteins being targeted instead for proteosomal degradation (18). Bag-1 associates with the proteosome in an ATP-dependent manner and promotes binding of Hsp70 to the proteolytic complex (19). Hsp90 has also been implicated in proteosomal degradation of client proteins (20).
Removal of client proteins by proteosomal degradation is a potential mechanism of Hsp anti-apoptotic activity, leading to cell survival and proliferation. By the same token, however, removal of proteins that are required for cell survival could be deleterious and result in apoptosis. An interesting question is whether Hsp modulate apoptosis strictly as a passive or active chaperone, or whether they can also function by a chaperone-independent protein-protein interaction. Recent data indicate that Hsp70 inhibits JNK and AIF independent of ATPase (chaperone) activity (21), suggesting that protein-protein interactions are also involved in the apoptosis regulatory activity of the Hsp.
Hsp bridge cell signaling/apoptotic pathways and the immune response
Because Hsp interact with the proteasome, they can function in antigen presentation and stimulation of the immune response. Recent data indicate that Hsp are components of the putative presentasome, an organized cellular region in antigen presenting cells (APC) in which proteins are degraded and peptides are loaded onto the major histocompatibility complex (MHC) class I and/or II for presentation to T cells (adaptive immunity) (Figure 2 ). Hsp family members bind to antigenic peptides and facilitate presentation (22, 23). In addition Hsp can be released into the extracellular compartment and Hsppeptide complexes are taken up by APC through the CD91 receptor for presentation on MHC class I and class II molecules (cross presentation) (22) (Figure 2 ). In addition Hsp also function as cytokines capable of stimulating antigen-independent (innate) immunity. Hsp70 induces APC to release inflammatory cytokines such as TNF-alpha, interleukin (IL)-1beta, IL-6 and RANTES through its interaction with the CD14/toll-like receptor (TLR) complex and promotes dendritic cell maturation (24, 25). Hsp70 ATPase activity does not appear to be required for induction of inflammatory cytokines or dendritic cell maturation, because the Hsp70 peptide binding fragment (amino acids 359-610) elicits a similar response (25). Thus, Hsp function both as intracellular chaperones/apoptosis modulators and stimulators of adaptive and innate immunity. By virtue of their ability to influence cell life and death decisions intracellularly and in the context of the immune response, Hsp are a logical target for virus modulation, for example within the context of immune evasion.
Hsp70
Hsp70 family members are the most conserved of all Hsp (26). Members can be either constitutively expressed (viz. Hsc70) or induced by a variety of stresses including hyperthermia, oxidation, or cytotoxic drugs (viz. Hsp70). Once expressed, Hsp70 influences protein folding, Figure 2 . Hsp70 inhibits apoptosis and is involved in immune regulation by modulating protein degradation and antigen presentation. Hsp70 inhibits apoptosis by interfering with the formation of the apoptosome by binding to Apaf thereby preventing caspase-9 and caspase-3 activation. It also inhibits apoptosis by directly interacting with either ASK-1 or JNK. Hsp70 can aid in the degradation of ubiquinated proteins by chaperoning them to the proteasome. Hsp70 also binds the remaining peptides from the degraded protein and facilitates their presentation on the cell surface with the major histocompatibility complex class I (MHC I). The Hsp70-peptide complex, extruded from neighboring non-immune cells or nearby antigen presenting cells (APC), is endocytosed by the APC and the peptide is presented on the surface with MHC II. The Hsp70-peptide complex also transverses the plasma membrane and enters the intracellular antigen presentation pathway resulting the peptide presentation on the surface with MHC I. prevents the formation of undesired protein aggregates, and when necessary, refolds misfolded proteins. Hsp70 facilitates the removal of damaged proteins by ubiquitinmediated proteosomal degradation. It drives a multiprotein degradation complex that includes Hsp90, p60Hop, and the C-termini of the Hsc70-interacting proteins, CHIP and CAIR-1. The demonstration of a shift in the clientchaperone protein binding from Hsp90 to Hsp70 under distinct conditions, supports the central role of Hsp70 in this complex (18). These Hsp70 properties are attributed to the molecular chaperone activity of Hsp70, which is accelerated by catalyzing ATP hydrolysis to ADP and by associating with co-chaperones (viz. Hip, Hop, and Bag-1) in order to regulate ATPase activity (12) . Significantly, however, Bag-1 also binds (and activates) Raf-1 kinase, a member of the PK signaling proteins. During periods of stress, the increased expression of Hsp70 competes for Bag-1, leading to downregulation of Raf-1 kinase activity and the arrest of DNA synthesis (27). Bag-1 also binds Bcl-2 increasing its stability and, thereby, its activity (28), providing a direct link for cross-talk between the two families.
In addition to maintaining the proper tertiary and quaternary state of various cellular proteins, Hsp70 has anti-apoptotic activity. Heat-induced expression of Hsp70 has been shown to reduce Fas-associated apoptosis in U937 macrophages (29) , and A549 cells stably transfected with Hsp70 were protected from hyperoxia. Other apoptotic stimuli against which Hsp70 confers protection include ceramide (30) , UV irradiation (31) , and nitric oxide (32) . The mechanism of Hsp70 mediated anti-apoptotic activity has been studied in some detail. Increased expression of Hsp70 inhibited caspase-3 mediated PARP cleavage by inhibiting the processing of procaspase-3, rather than caspase-3 activity (33) . A number of studies indicate that Hsp70 can also modulate apoptosis through direct proteinprotein interaction. Hsp70 binds to Apaf-1 through its carboxy-terminal EEVD motif and prevents the recruitment and processing of procaspase-9 to the apoptosome (34) . It can also regulate apoptosis by caspase independent mechanisms, for example by directly binding Ask-1 to prevent H 2 0 2 -induced apoptosis (35) (Figure 2 ). Hsp70 also inhibits JNK activation by direct binding (36) or by increasing the activity of a JNK phosphatase (37) . Finally, Hsp70 binds AIF and inhibits its translocation, thereby protecting from AIF-mediated apoptosis (21).
Significantly, Hsp70-mediated JNK and AIF inhibition is independent of ATPase (chaperone) activity, and involves direct protein binding (21, 36). However, chaperone activity is required for Hsp70-mediated caspase inhibition, as evidenced by the finding that Hsp70 inhibition of caspase-3 activation depends on ATPase activity. It seems, therefore, that the Hsp70 anti-apoptotic activity is both chaperone-dependent and independent, a choice that appears to be cell type specific and may be related to the duration and intensity of Hsp70 expression and the nature of the apoptotic stimulus. In the PEER Tlymphocyte cell line, transient Hsp70 expression blocked JNK activation, while activation was unaffected in cells that constitutively expressed Hsp70. Conversely, caspase-3 activation was inhibited by constitutively expressed Hsp70, while transiently induced Hsp70 was unable to inhibit caspase activation and PARP cleavage (33) . Caspase-3 activity was not inhibited in stably transfected WEHI-S fibrosarcoma cells that overexpress Hsp70, but the cells were protected from apoptosis, suggesting that: (i) Hsp70 can also protect downstream of caspase-3, and (ii) the mechanism of action is cell-type specific (38) . Supporting the conclusion that the role of Hsp70 in apoptosis regulation may be stimulus-specific, Hsp70 protected Jurkat cells from hyperthermia-induced apoptosis, but it enhanced Fas-mediated apoptosis on the same cells (16).
Hsp90
Hsp90 is constitutively expressed in most cells making up a large proportion of all cellular proteins (1-2%). Hsp90 has chaperone activity dependent on ATP hydrolysis. It interacts with specific proteins which include transcription factors, signaling PK, and nuclear hormone receptors (39) . It binds Raf-1 kinase and maintains activation of the Ras/Raf/MEK/ERK survival pathway by preventing Raf-1 degradation (40) . It also binds PI3-K and Akt, thereby maintaining the integrity of this survival pathway (41) . Hsp90 also interacts with other proteins to modulate apoptosis.
It binds to Apaf-1 preventing formation of the apoptosome and subsequent cleavage of caspase-9 (42). In HeLa cells, Hsp90 binds and stabilizes receptor interacting protein (RIP) which protects cells from tumor necrosis factor-alpha (TNF-alpha) induced apoptosis by deflecting the apoptotic signal towards NF-kB activation (43) . However, in U937 cells, increased expression of Hsp90 has been associated with increased susceptibility to apoptosis induced by TNF-alpha and cycloheximide, indicating that under specific conditions, Hsp90 could enhance pro-apoptotic signals (44).
Hsp27
The small Hsp subfamily consists of nine different proteins grouped together based on their relatively small size (15) (16) (17) (18) (19) (20) (21) (22) (23) (24) (25) (26) (27) (28) (29) (30) and the presence of a conserved alpha-crystallin motif. One of the best studied members of this group is Hsp27, which does not have ATPase activity. Hsp27 has energy-independent chaperone activity, the main function of which is to protect from protein aggregation (45) . Increased Hsp27 expression inhibits apoptosis induced by Fas, the kinase inhibitor staurosporin, and anticancer agents such as actinomycin-D or etoposide (46, 47) . Various pathways are responsible for this antiapoptotic activity. Hsp27 binds procaspase-3, inhibiting its processing (48) . It also binds to cytosolic cytochrome c, thereby preventing apoptosome formation (49, 50) . Hsp27 can also translocate to the mitochondria, where it prevents the release of pro-apoptotic signaling mediators such as cytochrome c and Smac/DIABLO (51, 52) . Significantly, Hsp27 phosphorylation by MAPKAP kinase-2 causes its dimerization and subsequent interaction with Daxx. By binding and sequestering Daxx, Hsp27 prevents Fas/Ask1/JNK induced apoptosis (53) . Like Hsp90, Hsp27 also interacts with Akt ensuring the maintenance of its kinase activity, which is important for survival of hyperthermia-stressed PC12 cells (54) . To protect from oxidative stress, Hsp27 restores depleted glutathione levels by promoting the activation of glucose-6-phosphate dehydrogenase (55) and it helps retain the overall structural integrity of the cell by binding and stabilizing F-actin microfilaments (56) .
In certain cell types, Hsp27 overexpression enhances proteosomal degradation of ubiquinated proteins in response to stress stimuli such as etoposide or TNF-alpha. Hsp27 binds to polyubiquitin chains as well as to the 26S proteosome and is involved in the degradation of the main inhibitor of NF-kB, I-kBalpha (57). However, unlike Hsp70 and Hsp90, Hsp27 was not shown to enhance pro-apoptotic stimuli.
H11, a novel Hsp with pro-apoptotic activity
H11 (also known as Hsp22 or HspB8), is a member of the small Hsp family which includes Hsp27. It was initially identified during the search for a homologue to the PK domain of the HSV-2 large subunit of ribonucleotide reductase (ICP10) (2). H11 contains a degenerate alpha-crystallin motif and its expression is upregulated by heat stress (1, 58) . However, it differs from canonical Hsp in that it is associated with the cell surface (2), it does not translocate to the nucleus upon heat shock ( Figure 3A) , and it has intrinsic auto-and transphosphorylating kinase activity (1,2,59,60). Using sequence analysis described after compilation of nuclear export sequences (NES) (61), putative leucine-rich NES motifs were identified in the H11 N-(residues 21-31) and C-(residues 157-166) termini ( Figure 3B ), presumably accounting for its cytosolic localization.
Like other Hsp, H11 has been associated with cell proliferation. Its overexpression in cardiac muscle 8) or not (lanes 1-2). They were harvested immediately thereafter (0hr; lanes 3-4) or allowed to recover at 37ºC for 4 hrs (lanes 5-6) or 8 hrs (lanes 7-8) before harvest. To prepare cytoplasmic (C) and nuclear (N) fractions, cell pellets were resuspended in lysis buffer (50 mM Tris pH 8, 50 mM NaCl, 1% NP-40, 1mM DTT and protease inhibitors) and centrifuged at 7000g for 1 min. The pellet was separated from the supernatant (cytoplasmic extract), resuspended in lysis buffer that contained 450 mM NaCl, and sonicated for 30 seconds (nuclear extract). The cytoplasmic and nuclear extracts were immunoblotted with antibody specific for H11. (B) Complete amino acid sequence of H11. Two putative nuclear export signal (NES) sequences are underlined and the alpha-crystallin motif is bolded leads to hypertrophy and cytoprotection from ischemia, mediated by Akt activation that does not require H11 kinase activity (59, 60) . It is overexpressed in many stomach tumors (1) and in proliferating human keratinocytes (3) and rat pheochromocytoma (PC12) cells. Interestingly, expression is significantly reduced/inhibited when keratinocytes (3) and PC12 cells (Figure 4 ) are induced to differentiate [by increased Ca 2+ ions or nerve growth factor (NGF), respectively]. In PC12 cells, H11 expression was significantly reduced by NGF differentiation when the cells were grown on plastic, but not when they were grown on collagen ( Figure 4A ).
Because collagen binds the NGF-responsive alpha1beta1 integrin receptor on PC12 cells (62) , the data implicate H11 in the alpha1beta1 integrin signaling pathway that functions in cell cycle arrest (63, 64) . However, H11 is not required for differentiation, because the cells were differentiated when grown under both conditions, as determined by neurite outgrowth. Figure 4B ) and this was associated with increased apoptosis, as determined by TUNEL (22 +/-2% and 65 +/-3%, TUNEL+ cells for Dox and no Dox, respectively) ( Figure 4C ). Consistent with the conclusion that H11 has pro-apoptotic activity, its expression was markedly decreased in certain tumors, notably melanoma (1). In these tumor cells, H11 expression was induced by treatment with the methylation inhibitor 5-aza-2' deoxycytidine (Aza-C) and induction was associated with apoptosis. Apoptosis involved the independent activation of the p38MAPK and caspase-3 pathways (1). Because p38MAPK activation is directly regulated by Lys 63 (K63)-linked polyubiquination (65), H11 may favor ubiquination, for example through chaperone activity. Kinase activity may also be involved in the H11 pro-apoptotic activity (1, 60) . In this context it may be important to point out that in cardiac myocytes, H11 pro-apoptotic acitivity appears to involve inhibition of casein kinase 2 (CK-2) activity (60).
Why is
Significantly, in some tumor cells (viz. HeLa and G361), H11 had a single amino acid substitution at residue 51 (H11-W51C) (1). This mutation results in 7 additional beta-turns in the predicted secondary structure and a significant increase in autokinase activity. Unlike the wild type, which triggers caspase-3 and p38MAPK dependent apoptosis, H11-W51C activates the Raf/MEK/ERK survival pathway and causes cell transformation. H11-W51C has dominant anti-apoptotic activity, as evidenced by the finding that stably transfected cells are protected from apoptosis induced by staurosporine or by transfection with the wild type H11 (1). Collectively, the data indicate that in certain tumor cells H11 is silenced by aberrant promoter hypermethylation while in others it is mutated to an anti-apoptotic and transforming phenotype. Such regulation was not previously described for other Hsp, but it is likely related to the pro-apoptotic activity of H11, which is undesirable from the standpoint of tumor development. The data also suggest that H11 is a promising target for cancer chemotherapy, since its forced expression triggers cell-type specific apoptosis.
It is tempting to point out that these properties resemble those previously described for the tumor suppressor protein p53. Classically, p53 induces apoptosis by a mechanism involving upregulation of pro-apoptotic genes, such as Fas and Bax (66, 67) , and its expression can be inhibited in tumor cells by promoter hypermethylation (68) . However, like the H11 cytoprotective activity in cardiac cells (59) , p53 protects lung cancer cells from UVinduced apoptosis by binding and inhibiting JNK, and by blocking caspase 3 activation (69). Like H11, p53 expression is also decreased by differentiation in various cell types (70) (71) (72) . Moreover, a single site mutation (replacement of Arginine 175 with Histidine) reverses its activity from pro-to anti-apoptotic (73) . Further studies are needed in order to identify the spectrum of H11 mutations, quantify the extent of H11 gene silencing by promoter hypermethylation, and determine their relationship to tumor development. Notwithstanding, the similarity of H11 to p53 underscores the commonality of strategies used by various genes to regulate apoptosis and indicates that Hsp play pivotal roles in cell life and death decisions.
As such Hsp are desirable targets for hijacking/modulation by virus infection.
VIRAL REGULATION OF APOPTOTIC SIGNALING

Viruses encode homologues to the anti-apoptotic cellular proteins, notably Bcl-2.
In the context of virus infection, the balance between cell survival and apoptosis often determines the relative success of virus replication. One mechanism of ensuring successful virus replication is to tip the balance away from apoptosis by inhibiting death receptor pathways, such as TNF. Viruses achieve this goal by encoding homologues of the cellular anti-apoptotic proteins which interfere with the extracellular (death receptor) apoptotic cascade ( Figure 1 ). For example, poxviruses encode several genes homologous to the TNF receptor. When secreted, these proteins effectively compete with the cellular receptor for TNF, thereby blocking activation of the extracellular apoptotic cascade (74) . Human herpes virus type 8 (HHV-8) encodes a FLIP homologue which interacts with FADD and procaspase-8, blocking the latter's activation and subsequent apoptosis (75) . Viruses also target downstream components of the apoptotic cascade. The 19 kDa protein encoded by the adenovirus E1B gene (E1B-19K) is a Bcl-2 homologue (76). It can directly bind to Bak and Bax, inhibiting their ability to oligomerize and act as mitochondrial membrane pores (77) . HHV-8 and Herpesvirus saimiri also encode Bcl-2 homologues (78, 79) . Despite their ability to bind and inhibit pro-apoptotic Bcl-2 family members, the viral Bcl-2 proteins evidence limited amino acid conservation (80) . The EBV Bcl-2 homologue, BHRF1, shares only 25% overall sequence identity with cellular Bcl-2, and the HHV-8 Bcl-2 homologue, HHV8-Bcl-2, has only 15% overall identity with its cellular counterpart (78, 81) .
Within the BH1 domain, BHRF1 and HHV8-Bcl-2 have 30% and 45% sequence identity with the BH1 domain of Bcl-2, respectively (78) . This similarity is far lower than the 90% sequence identity shared by the BH1 domains of cellular anti-apoptotic Bcl-2 family members.
However, comparison of solution structure for the HHV8 and cellular Bcl-2 proteins revealed similar structural properties within the BH domains (82) . Furthermore, both BHRF1 and HHV8-Bcl-2, have the same number of alphahelices and the same overall folding pattern as their cellular counterpart (82, 83) . A major structural difference between the viral and cellular Bcl-2 proteins is a significant shortening of the loop region connecting the alpha1 and alpha2 helices (82, 83) . This region contains a caspase-3 cleavage site that, when acted upon by caspase-3, leads to ablation of the Bcl-2 anti-apoptotic activity (84) . It also contains a phosphorylation site that inhibits Bcl-2 activity (85) . By lacking this loop region, the viral Bcl-2 proteins are resistant to caspase-3 cleavage and phosphorylation, thus maintaining their anti-apoptotic activity (86) . Relatively low sequence identity to their cellular counterparts is actually advantageous for the viral Bcl-2 homologues, because it removes key regulatory sites while maintaining a structure and function similar to those of the cellular Bcl-2 protein. Viruses also inhibit apoptosis by encoding homologues of the caspase inhibitor IAP, such as the baculovirus p35 protein (87).
Viruses alter expression/activation of PK signaling cascades
Another strategy used by viruses to regulate apoptosis is to alter the expression and activation of cellular apoptosis modulatory proteins.
PKs involved in intracellular signaling pathways are a major target of viral modulation. The hepatitis B virus HBVx protein and the EBV LMP1 protein upregulate expression of the epidermal growth factor receptor (EGFR) leading to activation of the ERK pathway (88, 89) . The bovine papilloma virus (BPV) E5 protein binds directly to the EGFR cytoplasmic domain, enhancing its kinase activity (90) and the human papilloma virus type 16 (HPV-16) E5 protein inhibits EGFR downregulation, presumably by direct binding (91) . Human cytomegalovirus activates ERK by inhibiting a phosphatase that dephosphorylates it (92) , and the HSV-2 protein ICP10PK activates Ras by binding the Grb2-Sos complex and by blocking the activity of the Ras inhibitory protein RasGAP (93) .
Viruses also modulate the PI3-K/Akt survival pathway. The EBV latency protein LMP1 binds to the noncatalytic p85 subunit of PI3-K leading to the activation of its catalytic domain (94) . A second EBV latency protein, LMP2A, interacts with Src, a tyrosine PK that activates the PI3-K/Akt pathway (95) . Pathway activation is believed to promote latency maintenance by inhibiting apoptosis. However, the EBV protein BRLF1 is expressed during latency reactivation, and it also activates PI3-K signaling, suggesting that PI3-K/Akt is involved in latency reactivation (96) . This is likely required in order to inhibit apoptosis long enough to allow for virus replication. Other viral genes that activate the PI3-K pathway by direct binding include HBVx (97) , the CMV envelope glycoproteins gB and gH (98) and the human immunodeficiency virus type 1 (HIV-1) Tat protein (99) . Viruses can also inhibit pro-apoptotic kinases, as is the case for the HIV-1 protein Nef, which binds and inhibits Ask-1 (100).
Viruses encode Hsp homologues
Very few viruses have been shown to encode homologues of Hsp family members. One of these, Closterovirus, is a plant RNA virus that encodes an Hsp70 homologue known as p65 (also known as Hsp70h) (101) . p65 is required for efficient virion assembly, and is involved in cell-to-cell virus movement, presumably through its association with microtubules (102) . It resembles Hsp70 in the ATPase domain (greater than 30% homology), and has functional ATPase activity (103) . However, p65 does not resemble the protein binding domain of Hsp70 family members, and it does not bind to denatured proteins (103) . ATPase-dependent chaperone activity was not described. Therefore, despite its similarity to Hsp70, p65 probably does not retain apoptosis modulatory activity.
To the extent of our knowledge, HSV-2 is the only human viral pathogen that encodes Hsp homologues. One of these is UL14 that has 27% sequence identity with the protein binding domain of Hsp70, but lacks ATPase activity. Like Hsp70, UL14 undergoes nuclear translocation after heat shock, it appears to aid in protein folding (104) , and it has anti-apoptotic activity (105) . The other HSV-2 gene that is an Hsp homologue is ICP10PK. ICP10PK is located at the amino-terminus of the viral large subunit of ribonucleotide reductase (R1; ICP10). It is unique to HSV as no other R1 protein has such a PK domain. This finding, originally interpreted to indicate that ICP10PK was coopted from a cellular gene (106) , is supported by the subsequent finding that it is homologous to H11 (2,3). ICP10PK has a degenerate crystallin motif similar to that in small Hsp family members (107) , and direct alignment with anchored PK motifs revealed 32% identity (23/71 identical residues) and 59% homology (42/71 identical and functionally homologous residues) between the H11 and ICP10 PK catalytic cores ( Figure 5A ). This level of sequence homology is similar to that seen for viral Bcl-2 homologues and their cellular counterparts. Presumably, in the process of its co-option, the cellular gene fell under the control of the viral R1 promoter, losing regulatory constraints while retaining ATPase-independent chaperone activity (107).
Viruses regulate Hsp expression
Viruses also regulate the expression of cellular Hsp. The adenovirus E1a protein upregulates Hsp70 by directly activating its promoter (108) and HSV1/2 increase Hsp70 expression, a function that is presumably mediated by the viral immediate early genes (109) . Other viruses, such as SV40, are also known to induce Hsp expression (110) . However, it is still unclear whether the purpose of Hsp upregulation is to control apoptosis and/or aid in protein folding.
In addition to being homologous to an Hsp, ICP10PK upregulates the expression of Hsp family members.
Immunoblotting with antibodies that recognize Hsp27 or both the constitutively expressed Hsc70 and inducible Hsp70, indicated that primary cortical cultures do not express Hsp27 and only minimally express Hsc70 ( Figure 5, lane 1) . However, Hsp70 was induced by HSV-2 as early as 30 Figure 5, lanes 4,5) . The sequential induction of different Hsp, suggests that they may function in a multiprotein complex in which client proteins are shifted from one chaperone to another in the process of their disposition. Hsp upregulation may contribute to the anti-apoptotic activity of ICP10PK by insuring removal of damaged and deleterious proteins. The upregulation of Hsp27 late in infection, when most of the protein is involved with its ribonucleotide function and virus progeny is generated, may insure energy-independent anti-apoptotic activity, that may also be related to the removal of undesirable (toxic) proteins (53, 57) . Interestingly, Hsp70 expression is also induced by viral genes other than ICP10PK late in infection ( Figure 5 ), supporting the conclusion that Hsp play an important role in virus infection.
5.5.
ICP10PK commandeers all the apoptosis regulatory families ICP10PK induces cell proliferation and survival, likely due to its anti-apoptotic activity which involves the activation of the Ras/Raf/MEK/ERK pathway, upregulation of the Hsp70 co-chaperone Bag-1 [which also activates the kinase Raf-1 (111)], stabilization of the anti-apoptotic protein Bcl-2, and activation of the transcription factor CREB. (8) . These properties are similar to those of the H11 mutant H11-W51C, which shares the same sequence identity to ICP10PK as the wild type H11, activates the MEK/ERK pathway and has anti-apoptotic activity (1). We conclude that virus acquisition of the cellular protein is advantageous from the standpoint of virus survival, because ICP10PK is required for virus growth, particularly in nondividing cells, such as neurons (93) . In this context, it is particularly significant that H11-W51C compensates for ICP10PK as evidenced by single step growth curves in HEK293 cells and HEK293 cells that constitutively express H11-W51C (TAG51). Indeed, the growth of the ICP10PK deleted mutant (ICP10deltaPK) in HEK293 cells, did not begin until 10 hrs p.i., as compared to 2 hrs p.i. for HSV-2 ( Figure 6A ). By contrast, growth onset was not delayed in TAG51 cells ( Figure 6B ). In these cells, H11-W51C compensates for ICP10PK by activating the ERK pathway, as evidenced by the finding that the growth of both HSV-2 and ICP10deltaPK was delayed when the cells were treated with the MEK-specific inhibitor PD98059 ( Figure 6C ).
CONCLUSION AND PERSPECTIVE
Viruses hijack cells by commandeering signaling cascades that determine the cell's life and death decisions. Apoptotic cascades are major targets of virus modulation. Protein families that regulate apoptosis and are altered by virus infection include the Bcl-2, IAP and signaling PK families. Hsp are an emerging family of apoptosis regulatory proteins that function as molecular chaperones in regulating homeostasis. Virtually all family members have been associated with thermotolerance and cytoprotection, attributed, at least in part, to apoptosis inhibition. However, in some cases of extreme stress, Hsp overload was shown to contribute to apoptosis and Hsp were shown to enhance certain apoptotic signals. A recent report that an Hsp family member (H11) has independent pro-apoptotic activity (1) establishes the Hsp as a bona fide family of apoptosis regulators consisting of both pro-and anti-apoptotic members. H11 is unique among Hsp in that it is constitutively associated with the cell surface, does not translocate to the nucleus upon heat shock, has intrinsic auto-and trans-phosphorylating kinase activity, and has pro-apoptotic activity in neuronally differentiated PC12 cells and cardiac myocytes and in certain tumor cells, notably melanoma (1, 2, 59, 60) . In tumor cells, its proapoptotic activity is circumvented through gene silencing by aberrant promoter hypermethylation or by mutation that ablates its pro-apoptotic activity. Indeed, a single amino acid mutation at residue 51 (H11-W51C) can lead to a reversal of its apoptosis modulatory activity from pro-to anti-apoptotic (1). throughout the course of the experiment) (C). Infection was in medium with 1% fetal bovine serum. Virus titers were quantified by plaque assay (2) and results are expressed as plaque forming units/ml (pfu/ml).
The exact mechanism of Hsp anti-or proapoptotic activity is still unclear. An interesting question is whether Hsp modulate apoptosis strictly by virtue of their chaperone activity or whether they can also regulate apoptosis by a chaperone-unrelated protein interaction. Hsp70, for example, complexes with nascent or damaged proteins and chaperones them for refolding and function resumption, or for degradation by the proteosome complex. The co-chaperone Bag-1 plays a crucial role in the decision whether client proteins will be refolded for resumed function or targeted to the proteosome for degradation (18, 19) . However, Bag-1 also has Hsp70-independent functions in apoptosis modulation including its ability to activate the Raf-1 kinase and stabilize Bcl-2 (111) . In this context, it is particularly significant that Bag-1 is expressed as distinct isoforms that arise from a common transcript through alternative in-frame translational start sites. One of these, Bag-1M inhibits the refolding reaction of Hsp70, while the other, Bag-1S displays stimulating activity (112) . Both isoforms could have anti-apoptotic activity, depending on whether refolding or degradation of the Hsp70 client protein is desirable for cell survival. However, Hsp function in apoptosis regulation is also chaperoneindependent (21). Hsp90 has also been implicated in proteosomal degradation of client proteins, often in a multiprotein complex in which the client protein is transferred from one to the other Hsp (18). The versatility of the Hsp in apoptosis regulation makes them particularly attractive targets for virus modulation.
HSV-2 appears to be unique among human viruses that modulate apoptosis in that it encodes proteins that are Hsp homologues and modulate apoptosis. One of these, ICP10PK, likely originated from H11 or its mutant H11-W51C through an ancestral recombination event. The similarity of ICP10PK and H11-W51C (both are antiapoptotic involving activation of the ERK survival pathway) and the ability of H11-W51C to compensate for ICP10PK during HSV-2 replication support this conclusion. However, unlike cellular Hsp, the ICP10PK promoter does not retain heat shock factor elements and its expression is regulated by AP-1 (113, 114) . By inserting the co-opted Hsp downstream of a strong viral promoter, HSV-2 gained the Hsp derived apoptosis-regulatory activity, while avoiding cellular regulation of gene expression. This is especially advantageous for virus replication during latency reactivation. In neurons, ICP10PK expression is induced by factors, such as AP-1, that are upregulated by reactivation stimuli (115, 116) and its anti-apoptotic activity is important for increasing the number of live neurons that can support virus replication. Indeed, previous studies have implicated ICP10PK in HSV-2 latency reactivation by showing that: (i) an HSV-2 mutant deleted in the PK domain of ICP10 is severely compromised for latency reactivation (117, 118), and (ii) HSV-2 reactivation from explanted ganglia is inhibited by an ICP10-specific antisense oligonucleotide (119).
Since Bag-1 transfection of primary hippocampal cultures can account for over 90% of the ICP10PK antiapoptotic activity (8) , the significance of the early upregulation of Hsp70 is not immediately apparent. A possible interpretation is that Hsp70 expression early during virus infection is important for chaperoning damaged proteins to the proteasome. The early upregulation of Bag-1 is consistent with this interpretation. The significance of Hsp27 upregulation by ICP10PK late during infection is also unclear. Because Hsp27 can chaperone ubiquitinated proteins to the proteasome in an ATP-independent manner (57), its upregulation late in infection, when the cell is likely to be energy depleted, may be advantageous. Another possibility is that ICP10 may be occupied with ribonucleotide reductace activity during the late phase of infection and thus Hsp27 may serve as a supplement to ICP10PK anti-apoptotic activity.
Targeting the Hsp family has an important additional advantage for the virus in that it allows for immune modulation. Indeed, HSV-2 infection induces both antiviral Th1 and immune downregulatory Th2 responses. A virus mutant deleted in ICP10PK shifts the balance of the virus-specific T cell response in favor of the Th1 component (120), indicating that ICP10PK functions in immune evasion by favoring the more virus-friendly Th2 response. This presumably involves the upregulation of Th2 polarizing and inflammatory cytokines, including IL-10, IL-6, IL-13, MCP-1 and RANTES in infected keratinocytes (Aurelian et al, in preparation). ICP10PK may be able to induce these cytokines because it is homologous to an Hsp and/or it upregulates Hsp70 expression. While additional studies are needed in order to better understand the role of Hsp in virus infection., it seems reasonable to conclude that by encoding an Hsp homologue, HSV-2 gains the advantage of targeting a wide range of apoptosis modulatory proteins that ensure host cell survival and thereby contribute to the virus life cycle.
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